Global Biotechnology - Market Summary, Competitive Analysis and Forecast to 2025
Global Biotechnology - Market Summary, Competitive Analysis and Forecast to 2025
SUMMARY
Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The global biotechnology market had total revenues of $529.1bn in 2020, representing a compound annual growth rate (CAGR) of 7.8% between 2016 and 2020.
- The Medical/Healthcare segment was the market's most lucrative in 2020, with total revenues of $302.6bn, equivalent to 57.2% of the market's overall value.
- In the wake of the COVID-19 pandemic, which has stalled the global economy and brought unprecedented levels of uncertainty in many sectors, the future of biotechnology is uncertain. However, in the mid to long-term the market should benefit from rising investment in medicines and government support, aiding growth.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalbiotechnology market
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts
- What was the size of the Global biotechnology market by value in 2020?
- What will be the size of the Global biotechnology market in 2025?
- What factors are affecting the strength of competition in the Global biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up the global's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Are there any notable threats to leading players in this market?
7.5. Are there any other notable players in the market?
7.6. How might the COVID-19 pandemic affect the competitive landscape?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. F. Hoffmann-La Roche Ltd
8.3. Novartis AG
8.4. Bayer AG
8.5. Takeda Pharmaceutical Company Limited
8.6. BioNTech SE
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Are there any notable threats to leading players in this market?
7.5. Are there any other notable players in the market?
7.6. How might the COVID-19 pandemic affect the competitive landscape?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. F. Hoffmann-La Roche Ltd
8.3. Novartis AG
8.4. Bayer AG
8.5. Takeda Pharmaceutical Company Limited
8.6. BioNTech SE
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Global biotechnology industry value: $ billion, 2016-20
Table 2: Global biotechnology industry category segmentation: $ billion, 2020
Table 3: Global biotechnology industry geography segmentation: $ billion, 2020
Table 4: Global biotechnology industry value forecast: $ billion, 2020-25
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: F. Hoffmann-La Roche Ltd: key facts
Table 10: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 11: F. Hoffmann-La Roche Ltd: Key Employees
Table 12: Novartis AG: key facts
Table 13: Novartis AG: Annual Financial Ratios
Table 14: Novartis AG: Key Employees
Table 15: Novartis AG: Key Employees Continued
Table 16: Bayer AG: key facts
Table 17: Bayer AG: Annual Financial Ratios
Table 18: Bayer AG: Key Employees
Table 19: Bayer AG: Key Employees Continued
Table 20: Takeda Pharmaceutical Company Limited: key facts
Table 21: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 22: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 23: Takeda Pharmaceutical Company Limited: Key Employees
Table 24: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 25: BioNTech SE: key facts
Table 26: BioNTech SE: Annual Financial Ratios
Table 27: BioNTech SE: Key Employees
Table 28: Global exchange rate, 2016-20
Table 1: Global biotechnology industry value: $ billion, 2016-20
Table 2: Global biotechnology industry category segmentation: $ billion, 2020
Table 3: Global biotechnology industry geography segmentation: $ billion, 2020
Table 4: Global biotechnology industry value forecast: $ billion, 2020-25
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: F. Hoffmann-La Roche Ltd: key facts
Table 10: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 11: F. Hoffmann-La Roche Ltd: Key Employees
Table 12: Novartis AG: key facts
Table 13: Novartis AG: Annual Financial Ratios
Table 14: Novartis AG: Key Employees
Table 15: Novartis AG: Key Employees Continued
Table 16: Bayer AG: key facts
Table 17: Bayer AG: Annual Financial Ratios
Table 18: Bayer AG: Key Employees
Table 19: Bayer AG: Key Employees Continued
Table 20: Takeda Pharmaceutical Company Limited: key facts
Table 21: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 22: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 23: Takeda Pharmaceutical Company Limited: Key Employees
Table 24: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 25: BioNTech SE: key facts
Table 26: BioNTech SE: Annual Financial Ratios
Table 27: BioNTech SE: Key Employees
Table 28: Global exchange rate, 2016-20
LIST OF FIGURES
Figure 1: Global biotechnology industry value: $ billion, 2016-20
Figure 2: Global biotechnology industry category segmentation: % share, by value, 2020
Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: Global biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the global biotechnology industry, 2020
Figure 6: Drivers of buyer power in the global biotechnology industry, 2020
Figure 7: Drivers of supplier power in the global biotechnology industry, 2020
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2020
Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2020
Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2020
Figure 1: Global biotechnology industry value: $ billion, 2016-20
Figure 2: Global biotechnology industry category segmentation: % share, by value, 2020
Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: Global biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the global biotechnology industry, 2020
Figure 6: Drivers of buyer power in the global biotechnology industry, 2020
Figure 7: Drivers of supplier power in the global biotechnology industry, 2020
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2020
Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2020
Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2020